glp-1 peptide therapy Diabetes & Peptides: Treatment & Research GLP-1 Oral Liquid Therapy for

Food Matters Live Podcast Dublin Conference.

Rishi P

Glucagon-like peptide-1 receptor agonists also lead to satiety and appetite reduction through action on the brains appetite regulation centers, leading to weight loss in obese patients

The use of GLP-1 drugs like Ozempic for weight loss is expected to boom in coming years

Safety issues like the black box warning for thyroid cancer risk are also addressed

Background Guidelines recommend combination therapy with glucagonlike peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) for cardiorenal risk reduction in people with type 2 diabetes (T2D)